Chronic Respiratory Infections by Mucoid Carbapenemase-Producing Pseudomonas aeruginosa Strains, a New Potential Public Health Problem
Authors:
Open Access
- 1 June 2008
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 52 (6) , 2285-2286
Abstract
Pseudomonas aeruginosa is a major cause of chronic respiratory infections (CRI) in patients with underlying diseases such as cystic fibrosis, bronchiectasis, or chronic obstructive pulmonary disease (COPD) ([1][1], [6][2], [7][3]). The establishment of P. aeruginosa CRI is driven by the acquisitionKeywords
This publication has 14 references indexed in Scilit:
- Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from Spanish HospitalsAntimicrobial Agents and Chemotherapy, 2007
- Resistance Mechanisms of Multiresistant Pseudomonas aeruginosa Strains from Germany and Correlation with HypermutationAntimicrobial Agents and Chemotherapy, 2007
- Nosocomial spread of Pseudomonas aeruginosa producing the metallo-β-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implicationsClinical Microbiology and Infection, 2007
- Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patientsProceedings of the National Academy of Sciences, 2006
- Hypermutation Is a Key Factor in Development of Multiple-Antimicrobial Resistance inPseudomonas aeruginosaStrains Causing Chronic Lung InfectionsAntimicrobial Agents and Chemotherapy, 2005
- Metallo-β-Lactamases: the Quiet before the Storm?Clinical Microbiology Reviews, 2005
- Pseudomonal Infections in Patients with COPDAmerican Journal of Respiratory Medicine, 2003
- Lung Infections Associated with Cystic FibrosisClinical Microbiology Reviews, 2002
- High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung InfectionScience, 2000
- Lung function in bronchiectasis: the influence of Pseudomonas aeruginosaEuropean Respiratory Journal, 1996